Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
PaxMedica, Inc. - Common stock
(OP:
PXMD
)
0.0777
+0.0037 (+5.00%)
Streaming Delayed Price
Updated: 3:04 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PaxMedica, Inc. - Common stock
New Computational Model Explains Behavioral and Neural Differences in ASD
December 05, 2024
Via
Investor Brand Network
Study Finds That Pollution Increases Autism Risk
November 15, 2024
Via
Investor Brand Network
Siblings of Autistic Kids Have Sevenfold Higher Risk of Autism
October 11, 2024
Via
Investor Brand Network
Study Links Iron Deficiency to Disturbed Sleep Among Autism, ADHD Patients
September 23, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Announces Immediate Exercise of Warrants to Total Approximately $884K
September 03, 2024
Via
Investor Brand Network
PaxMedica Secures Immediate Exercise of Warrants
September 03, 2024
Via
ACCESSWIRE
PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection
August 27, 2024
Via
ACCESSWIRE
Women with Autism Have Higher Odds of Being Misdiagnosed with BPD
July 17, 2024
Via
Investor Brand Network
Yale Study Unravels Autism, Brain Growth Patterns
August 30, 2024
Via
Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Provides Update on Its Response to Extraordinary Request to Provide PAX-101 to Malawi
August 27, 2024
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Committed to Global Health, Potential Positive Impact of PAX-101
August 22, 2024
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Preparing for NDA Submission for Leading Drug Candidate
August 05, 2024
Via
Investor Brand Network
Exposures
Product Safety
Study Shows Autism More Prevalent in Kids Living in Congested Areas
July 31, 2024
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders
July 25, 2024
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones
July 01, 2024
Via
Investor Brand Network
Exposures
Product Safety
New Research Suggests More Intervention May Not Increase Benefits for Autistic Kids
July 01, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Marks Major Milestone in Preparations for NDA Submission, Global Suramin Supply
June 13, 2024
Via
Investor Brand Network
Topics
Supply Chain
Exposures
Supply Chain
Researchers Say Brain ‘Overgrowth’ Could Contribute to Autism Development
June 12, 2024
Via
Investor Brand Network
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.